TLR9-mediated activation of dendritic cells by CD32 targeting for the generation of highly immunostimulatory vaccines

• Main Authors: J. A. Sepulveda-Toepfer (Author), Johannes Pichler (Author), Kathrin Fink (Author), Milica Sevo (Author), Sonja Wildburger (Author), Liesbeth Christiene Mudde-Boer (Author), Christopher Taus (Author), Geert Cornelius Mudde (Author)
• Format: Book
• Published: Taylor & Francis Group, 2019-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The rational for designing dendritic cell (DC)-targeted immunotherapies is their central role in orchestrating immunity. Most studies addressing antigen-targeting to DCs for eliciting T cell responses have employed ex-vivo matured DCs derived from monocytes or myeloid DCs isolated from peripheral bl...